1. Pharmaceutical policy in Italy

   • Livio Garattini
   • Dante Cornago

   Editorial Pages: 89 - 90

2. The reasons of general practitioners for promoting colorectal cancer mass screening in France

   • Célia Berchi
   • Jean-Marc Dupuis
   • Guy Launoy

   Original Papers Pages: 91 - 98

3. Choices and utilization in dental care

   • Lien Nguyen
   • Unto Häkkinen

   Original Papers Pages: 99 - 106

4. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer

   • Samuel Limat
   • Claire-Hélène Bracco-Nolin
   • Marie-Christine Woronoff-Lemsi

   Original Papers Pages: 107 - 113

   

5. Health care and patients’ migration across Spanish regions

   • David Cantarero

   Original Papers Pages: 114 - 116

6. The future of imaging techniques for cancer patients in The Netherlands

   • Theo J. B. M. Postma
   • Janneke C. Alers
   • Arjan Zuurbier

   Original papers Pages: 117 - 122

7. Factors influencing the costs of emergency medical admissions to an Irish teaching hospital

   • Edward D. Moloney
   • Kathleen Bennett
   • Bernard Silke

   Original Papers Pages: 123 - 128

8. Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers

   • Hans-Georg Eichler
   • Sheldon X. Kong
   • Jean-Pierre Grégoire

   Original Papers Pages: 129 - 136

9. Cost-effectiveness of memantine in community-based Alzheimer’s disease patients: an adaptation in Spain

   • Fernando Antonanzas
   • Benoit Rive
   • Chantal Guilhaume

   Original papers Pages: 137 - 144

   

10. Costs of chemotherapy in the treatment of colorectal cancer

    • F. G. A. Jansman
    • M. J. Postma

    Commentary Pages: 145 - 146

11. A taxonomy of health utility assessment methods and the role for uncertainty analysis

    • Agota Szende
    • Caroline Schaefer

    Commentary Pages: 147 - 151